Vimseltinib 14 mg; 20 mg; 30 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 14 mg; 20 mg; 30 mg
Reference Brands: Romvimza
Category: Oncology Cancer Care
Vimseltinib is used in adults to treat giant cell tumor of the tendon sheath (also called tenosynovial giant cell tumor) that is not likely to improve with surgery. Before taking this medicine, tell your doctor if you have or have ever had an allergy to aspirin or food dye or liver disease. Vimseltinib can harm an unborn baby if the mother or the father is using vimseltinib.
Product Description:
Vimseltinib, an investigational oncology drug, is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality according to GMP standards. In the US, regulatory review involves validation, safety assessments, and clinical trial data submission. In the EU, approval processes include validation, stability testing, and conformity with MDR standards. These dossiers encompass safety profiles, clinical trial results, and manufacturing practices
Vimseltinib — third party manufacturing & bulk supply
Vimseltinib 14 mg; 20 mg; 30 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Vimseltinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Vimseltinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Vimseltinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Vimseltinib is used for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgical removal of the tumor would cause severe complications or functional disability. It works by blocking the CSF1R receptor, which helps reduce the growth and spread of tumor cells in the affected joints or tissues.
Vimseltinib is a small-molecule compound formulated as oral capsules. It contains the active ingredient vimseltinib, a selective colony-stimulating factor 1 receptor (CSF1R) inhibitor. The capsules also include inactive ingredients such as lactose monohydrate, crospovidone, and magnesium stearate.
The trade name of Vimseltinib is Romvimza.
Vimseltinib is developed and manufactured by Deciphera Pharmaceuticals, LLC, which is part of the Ono Pharmaceutical Group.
The generic name of the product is Vimseltinib.
The brand name of the product is Romvimza.
Vimseltinib (Romvimza) is manufactured by Deciphera Pharmaceuticals, LLC at its facility in Waltham, Massachusetts, USA.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
